Get started
Author

Mei Ching Ong

Observed institution: Health Sciences Authority
OpenAlex ID: A5046810740
United Nations Office on Drugs and Crime: Recommended methods for the Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in Seized Materials
2021 · Justice N.A. Tettey, Conor Crean, et al. · Forensic Science International Synergy · 59
Simultaneous analysis of 2Cs, 25-NBOHs, 25-NBOMes and LSD in seized exhibits using liquid chromatography–tandem mass spectrometry: A targeted approach
2019 · Xue Wei Sarah Chia, Mei Ching Ong, et al. · Forensic Science International · 30
Technical note: Unequivocal identification of 5-methoxy-DiPT with NOESY NMR and GC-IRD
2020 · Hui Zhi Shirley Lee, Joo Yee Joey Ng, et al. · Forensic Science International · 9
Challenges in GC–MS analysis: Case studies on phenibut and ethylphenidate
2017 · Hui Zhi Shirley Lee, Mei Ching Ong, et al. · Forensic Science International · 9
Stability studies of ALD ‐52 and its homologue 1P‐LSD
2023 · Shu‐Hua Zhang, Angeline S. Y. Tang, et al. · Journal of Forensic Sciences · 8
PDF
Technical note: N-Isopropylbutylone unveiled – Differentiating the new synthetic cathinone in ecstasy from its close analogues with GC-MS and NMR spectroscopy
2025 · Hui Zhi Shirley Lee, Mei Ching Ong, et al. · Forensic Science International · 6
Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income Countries
2024 · Edward Lloyd Briercheck, J. Michael Wrigglesworth, et al. · JAMA Network Open · 5
PDF
Synthesis, characterization and differentiation of the structural isomers of valine and tert ‐leucine derived synthetic cannabinoids
2023 · Sui Boon Derek Sim, Hui Zhi Shirley Lee, et al. · Drug Testing and Analysis · 3
PDF
POSTER: CLL-1118: Early Outcomes of a Multistakeholder Treatment Access Program for Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal
2026 · Lauren Herzog, Alicia Annamalay, et al. · Clinical Lymphoma Myeloma & Leukemia
CLL-1118: Early Outcomes of a Multistakeholder Treatment Access Program for Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal
2026 · Lauren Herzog, Alicia Annamalay, et al. · Clinical Lymphoma Myeloma & Leukemia
Delta-8-THC acetate-a prodrug of delta-8-THC?: A case report
2025 · Jonathan Wong, Evelyn Mei Ling Goh, et al. · Forensic Science International Reports
Access to innovative treatment for paroxysmal nocturnal hemoglobinuria in low- and middle-income countries
2025 · Andrielle Yost, Mercedes Arteaga, et al. · Blood
Evaluating Barriers and Opportunities in Advanced Breast Cancer Care: Institutional Capacity Assessments in 16 Low- and Middle-income Countries
2025 · Alicia Annamalay, Mercedes Arteaga, et al. · The Breast
POSTER: CLL-710 Early Outcomes of a Treatment Access Program for Patients With Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal
2025 · Andrielle Yost, Karen Meliksetyan, et al. · Clinical Lymphoma Myeloma & Leukemia
CLL-710: Early Outcomes of a Treatment Access Program for Patients With Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal
2025 · Andrielle Yost, Karen Meliksetyan, et al. · Clinical Lymphoma Myeloma & Leukemia
CML-143 Treatment Free Remission in CML in Lower Resource Setting: A Single-Center Experience
2024 · Karen Meliksetyan, Astghik Voskanyan, et al. · Clinical Lymphoma Myeloma & Leukemia
Synthesis and applications of new chiral organocatalysts based on cis-1,2-diaminocyclohexane and Asymmetric Nozaki-Hiyama allylation of aldehydes
2011 · Mei Ching Ong · Kölner Universitäts PublikationsServer (Universität zu Köln)
Works count: 17
Citation count: 129
H-index: 6
I10-index: 2
Year
Topic
Type